SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
SEC Accession No. 0001052918-12-000014
Filing Date
2012-01-12
Accepted
2012-01-12 14:38:09
Documents
7
Period of Report
2011-06-30
Filing Date Changed
2012-01-12

Document Format Files

Seq Description Document Type Size
1 ALDA PHARMACEUTICALS CORP. FORM 20-F alda20fjan1211f.htm 20-F 977197
2 CERTIFICATION ex121.htm EX-12 7426
3 CERTIFICATION ex122.htm EX-12 7336
4 CERTIFICATION ex131.htm EX-13 2371
5 CERTIFICATION ex132.htm EX-13 2306
6 alda20fjan1211f002.gif GRAPHIC 54749
7 alda20fjan1211f004.gif GRAPHIC 4393
  Complete submission text file 0001052918-12-000014.txt   1079401
Mailing Address 1518 - 1030 WEST GEORGIA STREAT VANCOUVER A1 V6E 2Y3
Business Address 1518 - 1030 WEST GEORGIA STREAT VANCOUVER A1 V6E 2Y3 6048623439
ALDA Pharmaceuticals Corp. (Filer) CIK: 0001355736 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 20-F | Act: 34 | File No.: 000-51848 | Film No.: 12523995
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1